Immune-related gene expression profiling and alectinib efficacy for patients with ALK-Rearranged non–small cell lung cancer: exploratory analysis of a prospective observational study
Year: 2026
Type: article
Source: Lung Cancer
Authors: Takashi Kurosaki, Shinichiro Suzuki, Yasutaka Watanabe, Hirotsugu Kenmotsu, Shoichi Itoh, Masafumi Yamaguchi, Ayako Shiono, Takuji Suzuki, Toshihide Yokoyama, Yukihiro Toi, Hisashi Tanaka, Masahide Oki, Takeshi Tsuda, Eiki Ichihara, Koichi Azuma, Hiroshi Tanaka, Ryo Arai, Ken Uchibori, Eisaku Miyauchi, Ryohei Katayama, Hidetoshi Hayashi
Institutions: Kindai University, Saitama Cancer Center, Shizuoka Cancer Center, Hyogo Prefectural Cancer Center, National Hospital Organization Kyushu Cancer Center, Saitama International Medical Center, Saitama Medical University, Chiba University, Kurashiki Central Hospital, Sendai Kousei Hospital, Hirosaki University, Niigata Cancer Center Hospital, Nagoya Medical Center, Toyama Prefectural Central Hospital, Okayama University Hospital, Kurume University, Dokkyo Medical University, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, Tohoku University, Tohoku University Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Chugai Pharmaceutical
OpenAlex ID: W7154889751